Succinylcholine is a depolarizing skeletal muscle relaxant consisting of two molecules of the endogenous neurotransmitter acetylcholine (ACh) linked by their acetyl groups. It has been widely used for over 50 years, most commonly in its chloride salt form, as a means of neuromuscular blockade during intubation and surgical procedures. Its rapid onset and offset, with effects beginning within 60 seconds of intravenous administration and lasting between four to six minutes, make succinylcholine particularly useful in the setting of short medical procedures requiring brief periods of muscle relaxation.
Succinylcholine is indicated as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Harborview Medical Center, Seattle, Washington, United States
Dr. Horst Schmidt Klinik, Wiesbaden, Hessen, Germany
Dr. Horst Schmidt Klinik GmbH, Wiesbaden, Germany
General University Hospital in Prague, Prague, Czechia
St Patrick's University Hospital, Dublin, Ireland
Dr. Horst Schmidt Kliniken, Wiesbaden, Germany
Hopital Foch, Suresnes, Ile de France, France
University Hospital of Geneva, Anesthesia Department, Geneva, Canton of Geneva, Switzerland
Division of Anaesthesiology, University Hospital of Lausanne (CHUV), Lausanne, Vaud, Switzerland
Massachusetts General Hospital, Boston, Massachusetts, United States
Cleveland Clinic Foundation, Cleveland, Ohio, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.